Credit Suisse Boosts Price Target, Estimates on DR Horton (DHI)

Credit Suisse Boosts Price Target, Estimates on DR Horton (DHI)


According to analysts at Credit Suisse, DR Horton Inc. (DHI) will see higher sales going forward, which should lead to margin expansion. As such, the analysts raised the price target and earnings estimates through 2014 on the home builder.

The analysts maintain an “Outperform” rating on DHI and now see shares reaching $28. This new valuation suggests a 5% upside to Friday’s closing price of $26.66.

DR Horton shares were up 34 cents, or +1.28%, during pre-market trading on Monday. The stock is up +30.75% year-to-date.

The Bottom Line
Shares of DR Horton (DHI) have a dividend yield of 2.25% based on Friday’s closing price of $26.66 and the company’s annualized dividend payout of 60 cents per share.

DR Horton Inc. (DHI) is not recommended at this time, holding a DARS™ Rating of 3.2 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Free Updates

Join over 100,000 investors who get the latest news from

Best Dividend Stocks

Looking for stocks that are poised for growth and pay solid dividends? Visit our list of the:

Best Dividend Stocks

Partner Center

Best CD Rates

Sitting on some extra cash and looking for the most current and profitable CD Rates?

Get The Best CD Rates

14 Day Free Trial

Earn more from your dividend portfolio within the next 14 days.

Sign Up Today